Results
Type
Country of origin
Qualifications

Ibrutinib | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Ibrutinib. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Beijing THTD Pharmaceutical Technology Co., Ltd.

MOQ: 50 g
Type: Producer
Origin: China
China
MSN Labs.

MOQ: 0 kg
Type: Producer
Origin: India
India
Shanghai Bncscitech Co., Ltd

MOQ: 1 kg
Type: Producer
Origin: China
China
Shandong Octagon Chemicals Limited

MOQ: 100 g
Type: Producer
Origin: China
China
Dr. Reddy's


Type: Producer
Origin: India
India
Hetero Labs


Type: Producer
Origin: India
India
Scinopharm


Type: Producer
Origin: Taiwan
Taiwan
Alembic Pharma


Type: Producer
Origin: India
India
Teva


Type: Producer
Origin: Israel
Israel
Shilpa Medicare


Type: Producer
Origin: India
India
Natco Pharma


Type: Producer
Origin: India
India
Cipla


Type: Producer
Origin: India
India
Beijing Lunarsun Pharma


Type: Producer
Origin: China
China
Fresenius Kabi Onc.


Type: Producer
Origin: India
India
Wisdom Pharma


Type: Producer
Origin: China
China
Chengdu Firster Pharmaceutical Co Ltd


Type: Producer
Origin: China
China

Looking for Ibrutinib 936563-96-1?

API | Excipient name:
Ibrutinib 
Synonyms:
 
Cas Number:
936563-96-1 
DrugBank number:
DB09053 
Unique Ingredient Identifier:
1X70OSD4VX

About Ibrutinib

Do you want to know more about Ibrutinib? You can find a small explanation about it here. Ibrutinib is a small molecule that acts as an irreversible potent inhibitor of Burton's tyrosine kinase. It is designated as a targeted covalent drug and it presents a very promising activity in B cell malignancies. Ibrutinib was developed by Pharmacyclics Inc and in November 2013 was FDA-approved for the treatment of mantle cell lymphoma.

Later, in February 2014, ibrutinib was approved for the treatment of chronic lymphocytic leukemia and it is also indicated for the treatment of patients with Waldenström's Macroglobulinemia. Ibrutinib has also been approved by the EMA for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma. Ibrutinib was approved for use in chronic graft versus host disease in August 2017.

Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.

Ibrutinib manufacturers | traders | suppliers
We have 16 companies offering Ibrutinib from 4 different countries.

Get in contact with the supplier of your choice:

  • Beijing THTD Pharmaceutical Technology Co., Ltd. from China
  • MSN Labs. from India
  • Shandong Octagon Chemicals Limited from China
  • Shanghai Bncscitech Co., Ltd from China
  • Shilpa Medicare from India
  • Dr. Reddy's from India
  • Natco Pharma from India
  • Hetero Labs from India
  • Teva from Israel
  • Alembic Pharma from India
  • Scinopharm from Taiwan
  • Fresenius Kabi Onc. from India
  • Wisdom Pharma from China
  • Cipla from India
  • Beijing Lunarsun Pharma from China
  • Chengdu Firster Pharmaceutical Co Ltd from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.